THIS COURSE HAS BEEN DEVELOPED FOR BAYLOR SCOTT & WHITE EMPLOYEES AND AFFILIATES ONLY. 
Outside participation is not available for the Art of Communication courses at this time.

Please click the "Register Tab" above to register for this session.

THIS COURSE HAS BEEN DEVELOPED FOR BAYLOR SCOTT & WHITE EMPLOYEES AND AFFILIATES ONLY. 
Outside participation is not available for the Art of Communication courses at this time.

Please click the "Register Tab" above to register for this session.

Please click "Take Course" to evaluate and claim credit.

Coronary artery disease is a leading cause of mortality worldwide, and patients with obstructive coronary artery disease require optimal cardiovascular medical therapy along with lifestyle modification for secondary prevention of future cardiac events. Optimal medical therapy includes antiplatelet agents, high-intensity statins, beta-blockers, angiotensin-converting enzyme inhibitors or angiotensin II receptor blockers, aldosterone antagonists, and calcium channel blockers. There are differences in the medical therapy guidelines of the American Heart Association/American College of Cardiology and the European Society of Cardiology. In addition, there are emerging medical therapies that may be added to future guidelines with additional cardiovascular outcome benefits.

THIS COURSE HAS BEEN DEVELOPED FOR BAYLOR SCOTT & WHITE EMPLOYEES AND AFFILIATES ONLY. 
Outside participation is not available for the Art of Communication courses at this time.

Please click the "Register Tab" above to register for this session.

THIS COURSE HAS BEEN DEVELOPED FOR BAYLOR SCOTT & WHITE EMPLOYEES AND AFFILIATES ONLY. 
Outside participation is not available for the Art of Communication courses at this time.

Please click the "Register Tab" above to register for this session.

The effects of polypharmacy on geriatric populations are an emerging concern that merits more exploration. The primary goal of this review was to evaluate the current body of knowledge on polypharmacy and explore the preventive and corrective measures to avoid negative outcomes. Even if a medication has an appropriate indication, polypharmacy in the geriatric population is associated with an increased risk of drug-drug or drug-condition interactions. Recent efforts to prevent polypharmacy include the development of interprofessional teams in clinics dedicated to medication review and reconciliation, deprescription plans aimed to safely discontinue potentially inappropriate medications, and inpatient screening tools that provide prescribing recommendations. In conclusion, polypharmacy affects a high percentage of the geriatric population. Current efforts to address and prevent polypharmacy are ongoing but have not been widely adopted.

Pages

Subscribe to RSS - Medical Knowledge